PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Down 97.7% in March

PURE Bioscience, Inc. (OTCMKTS:PURE) was the target of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 400 shares, a decline of 97.7% from the February 29th total of 17,200 shares. Based on an average trading volume of 44,000 shares, the days-to-cover ratio is presently 0.0 days.

PURE Bioscience Stock Up 12.5 %

Shares of PURE traded up $0.01 during trading on Thursday, reaching $0.10. The company’s stock had a trading volume of 24,000 shares, compared to its average volume of 18,569. PURE Bioscience has a twelve month low of $0.07 and a twelve month high of $0.17. The company has a quick ratio of 1.59, a current ratio of 1.72 and a debt-to-equity ratio of 3.75. The company has a market cap of $11.07 million, a price-to-earnings ratio of -1.65 and a beta of 0.09. The company has a fifty day moving average of $0.10 and a two-hundred day moving average of $0.11.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.